The results of the CoviPrev survey cover the following topics: mental health, adherence to preventive measures, vaccination uptake, substance use, diet, and physical activity.

Changes in mental health during the COVID-19 pandemic

• Mental Health - Results from Wave 37 of the CoviPrev survey

• Mental health - Results from Wave 36 of the CoviPrev survey

• Mental health - Results from Wave 35 of the CoviPrev survey

• Mental health - Results of Wave 34 of the CoviPrev survey

• Mental Health - Results from Wave 33 of the CoviPrev Survey

• Mental Health - Results from Wave 32 of the CoviPrev Survey

• Mental Health - Results from Wave 31 of the CoviPrev Survey

• Mental Health - Results from Wave 30 of the CoviPrev Survey

• Mental Health - Results from Wave 29 of the CoviPrev Survey

• Mental Health - Results from Wave 28 of the CoviPrev Survey

• Mental Health - Results from Wave 27 of the CoviPrev Survey

• Mental Health - Results from Wave 26 of the CoviPrev Survey

• Mental Health - Results from Wave 25 of the CoviPrev Survey

• Mental Health - Results from Wave 24 of the CoviPrev Survey

• Mental Health - Results from Wave 23 of the CoviPrev Survey

• Mental Health - Results from Wave 22 of the CoviPrev Survey

Trends in Adherence to Vaccination and Preventive Measures Against COVID-19

• How is the French public’s adherence to preventive measures against winter viruses evolving? Results of Wave 38 of the CoviPrev survey

• How is the French public’s adherence to preventive measures against winter viruses changing? Results from Wave 37 of the CoviPrev survey

• How is the French public’s adherence to preventive measures against COVID-19 changing? Results from Wave 36 of the CoviPrev survey

• How is the French public’s adherence to preventive measures against COVID-19 changing? Results from Wave 35 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 34 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 33 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 32 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 31 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 30 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 29 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 28 of the CoviPrev survey

• How is the French public’s adherence to COVID-19 prevention measures changing? Results from Wave 27 of the CoviPrev survey

• Adherence to vaccination and preventive measures - Results from Wave 26 of the CoviPrev survey

• Adherence to vaccination and preventive measures - Results from Wave 25 of the CoviPrev survey

Flash# surveys are conducted at regular intervals and help map SARS-CoV-2 variants across France.

Molecular evolution of SARS-CoV-2 viruses circulating in France

• Results of Flash Survey #29

• Results of Flash Survey #28

• Results of Flash Survey #27

• Results of Flash Survey #26

• Results of Flash Survey #25

• Results of Flash Survey #24

• Results of Flash Survey #23

• Results of Flash Survey #22

• Results of Flash Survey #21

• Results of Flash Survey #20

• Results of Flash Survey #19

• Results of Flash Survey #18

• Results of Flash Survey #17

• Results of Flash Survey #16

• Results of Flash Survey #15

• Results of Flash Survey #14

• Results of Flash Survey #13

• Results of Flash Survey #12

• Results of Flash Survey #11

• Results of Flash Survey #10

• Results of Flash Survey #9

• Results of Flash Survey #8

• Results of Flash Survey #7

• Results of Flash Survey #6

• Results of Flash Survey #5

• Vaccination uptake among older adults for vaccines against acute respiratory infections. Results of the IRAPrev survey (March 28–April 14, 2025)

• Trends in emergency room visits and Drug Info Service inquiries related to cocaine use between 2012 and 2024

• Vaccination coverage against influenza and COVID-19 among residents and staff in social and medico-social institutions (ESMS). Update as of July 18, 2025.

• Tobacco and alcohol use during pregnancy. Results of the 2021 Public Health France Barometer.

• Mental health and well-being of middle and high school students in mainland France. Results of the 2022 EnCLASS survey

• Characteristics of COVID-19 cases hospitalized in adult intensive care units in France between October 2020 and April 2023. As of August 29, 2023.

• Evaluation of the adolescent mental health campaign: “I’ll talk to.” Update as of March 9, 2023.

• Reporting of nosocomial SARS-CoV-2 infections. March 2020–November 2022. Update as of December 1, 2022.

• Risks of SARS-CoV-2 reinfection. Update as of September 15, 2022.

• Post-COVID-19 condition (also known as long COVID) in France. Update as of July 21, 2022.

• Risks of SARS-CoV-2 reinfection. Update as of July 7, 2022.

• Reporting of nosocomial SARS-CoV-2 infections. March 2020 – June 2022. Update as of June 23, 2022.

• Analysis of available data on possible SARS-CoV-2 reinfection from the SIDEP database. Update as of May 12, 2022.

• Changes in physical activity levels and sedentary behavior among the French population one year after the strict lockdown of 2020. Update as of May 11, 2022.

• What is the COVID-19 vaccination coverage among healthcare professionals and residents in long-term care facilities? Update as of April 21, 2022.

• Reporting of nosocomial SARS-CoV-2 infections. March 2020 – April 2022. Update as of April 14, 2022.

• Analysis of available data on possible SARS-CoV-2 reinfections from the SIDEP database. Update as of March 31, 2022.

• Evaluation of the adolescent mental health campaign: “I’m talking to.” Update as of March 14, 2022.

• Evaluation of the adult mental health campaign: “Talking about it is already part of the healing process.” As of March 14, 2022.

• Real-world effectiveness of vaccination in preventing symptomatic COVID-19 infections. Update as of February 24, 2022.

• Reporting of nosocomial SARS-CoV-2 infections. March 2020–February 2022. As of February 24, 2022.

• Analysis of available data on possible SARS-CoV-2 reinfections from the SIDEP database. Update as of February 17, 2022.

• What accounts for the increase in mortality observed since November 2021? Update as of February 10, 2022.

• Reporting of nosocomial SARS-CoV-2 infections, March 2020–January 2022. As of January 20, 2022.

• What is the COVID-19 vaccination coverage among healthcare professionals and residents in long-term care facilities? Update as of December 23, 2021.

• Reporting of nosocomial SARS-CoV-2 infections, March 2020–November 2021. Update as of December 2, 2021.

• Trends in epidemic indicators among 5- to 11-year-olds and comparison with 12- to 17-year-olds. As of October 31, 2021.

• What is the COVID-19 vaccination coverage among vulnerable populations? Update as of October 21, 2021.

• What is the COVID-19 vaccination coverage among healthcare professionals? Data as of September 20, 2021

• What is the attitude of private practice healthcare professionals toward COVID-19 vaccination?

• COVID-19 vaccination coverage among healthcare professionals working in healthcare facilities

• Trends in epidemic and vaccination indicators among children and students. Update as of September 9, 2021.

• Epidemiological situation regarding COVID-19 among children and adolescents aged 0–17. Update as of January 12, 2023.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of December 1, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of October 20, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of September 25, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of August 25, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of July 7, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of May 19, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of April 14, 2022.

• Epidemiological situation related to COVID-19 among children and adolescents aged 0–17. Update as of January 13, 2022.

• How has the SARS-CoV-2 epidemic evolved among children under 18 during the school year?

National surveillance of cases of pediatric multisystem inflammatory syndrome (PIMS)

Following the alert issued by pediatricians at AP-HP hospitals in late April 2020, Santé publique France and pediatric medical societies established surveillance of myocarditis cases in children with COVID-19 infection.

• Learn more

• View reports produced through March 2022